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Background: In countries with high incomes, frailty indicators predict adverse outcomes in older people, despite a
lack of consensus on definition or measurement. We tested the predictive validity of physical and multidimensional
frailty phenotypes in settings in Latin America, India, and China.
Methods: Population-based cohort studies were conducted in catchment area sites in Cuba, Dominican Republic,
Venezuela, Mexico, Peru, India, and China. Seven frailty indicators, namely gait speed, self-reported exhaustion, weight
loss, low energy expenditure, undernutrition, cognitive, and sensory impairment were assessed to estimate frailty
phenotypes. Mortality and onset of dependence were ascertained after a median of 3.9 years.
Results: Overall, 13,924 older people were assessed at baseline, with 47,438 person-years follow-up for mortality
and 30,689 for dependence. Both frailty phenotypes predicted the onset of dependence and mortality, even adjusting
for chronic diseases and disability, with little heterogeneity of effect among sites. However, population attributable
fractions (PAF) summarising etiologic force were highest for the aggregate effect of the individual indicators, as
opposed to either the number of indicators or the dichotomised frailty phenotypes. The aggregate of all seven
indicators provided the best overall prediction (weighted mean PAF 41.8 % for dependence and 38.3 % for mortality).
While weight loss, underactivity, slow walking speed, and cognitive impairment predicted both outcomes, whereas
undernutrition predicted only mortality and sensory impairment only dependence. Exhaustion predicted neither
outcome.
Conclusions: Simply assessed frailty indicators identify older people at risk of dependence and mortality, beyond
information provided by chronic disease diagnoses and disability. Frailty is likely to be multidimensional. A better
understanding of the construct and pathways to adverse outcomes could inform multidimensional assessment
and intervention to prevent or manage dependence in frail older people, with potential to add life to years, and
years to life.
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Most definitions of frailty share two core features; firstly,
an underlying progressive age-related decline in physiologic
systems, with large individual variation, and second, a
consequent decreased functional reserve capacity, confer-
ring vulnerability for failure in the face of environmental
stressors [1]. Sustained interest in the construct stems
mainly from its predictive validity, confirmed through
increased risks of adverse health and social outcomes
for older people – morbidity, hospitalization, falls and frac-
tures, disability, dependence, institutionalization and death
[2–5]. The process of becoming frail may be delayed,
slowed, or even partly reversed by interventions targeted
early in the process of functional decline [6]. Trials of com-
plex interventions, designed to promote independence in
moderately frail older people have shown potential ben-
efits. These are important findings with global implica-
tions [7–9]. Population ageing is proceeding apace in all
world regions, but the populations of many low-, and par-
ticularly middle-income countries are ageing more rapidly
than any country in the past; two-thirds of the world’s
older people live in low- and middle-income countries
(LMICs), rising to 80 % by 2050 [10]. While morbidities
mediate the relationship between population ageing and
societal costs, the relationships with chronological age are
variable, and potentially amenable to influence from pub-
lic health, health, and social care interventions [11].
A clearer understanding of the nature of the frailty
construct, and its relations to adverse outcomes is needed
to inform and prioritise intervention strategies. Dissatis-
faction has been expressed with current models of frailty
and approaches to measurement, with at least seventeen
different conceptual definitions proposed [12–14]. As
originally defined by Fried et al.[4], frailty was a unidi-
mensional, largely physical construct identified by the
presence of three or more of five indicators – exhaustion,
weight loss, weak grip strength, slow walking speed, and
low energy expenditure. Others have proposed widening
the scope to include, for example, cognitive or sensory do-
mains [15, 16]. Incorporating diseases and disability has
been particularly controversial [3]; if frailty represents an
underlying vulnerability, then disease and disability may
be among the predicted outcomes rather than part of the
construct itself. ‘Frailty indices’ neglect this distinction,
assessing age-dependent accumulation of a wide range of
health indicators; symptoms, signs, conditions, diseases,
and disabilities [17, 18].
In summary, it is unclear whether frailty is best con-
sidered a unidimensional or multidimensional construct.
Its boundaries remain unclear, with tentative evidence to
support the inclusion of cognitive ageing as a relevant
aspect of frailty. We therefore set out to test, empirically,
the utility of two widely applied frailty constructs, the
physical frailty phenotype, as originally conceptualisedby Fried et al.[4], and a broader, multidimensional frailty
model based on deficiencies in physical, nutritive, cogni-
tive, and sensory domains of functioning [16, 17]. We
had three questions. Are older people defined as frail ac-
cording to these paradigms at higher risk of dependence
and death, even after controlling for major chronic dis-
eases and disability? Does the aggregate of the individual
indicators provide a better prediction of these outcomes
(judged by population attributable fraction (PAF) derived
from multivariable models) than the dichotomised or
ordinal frailty scores? Are different frailty indicators
differentially associated with the incidence of depend-
ence and mortality? We addressed these questions in a
large population-based cohort study in seven LMICs, in
which settings little previous research into frailty has
been conducted.Method
Settings and study design
The 10/66 Dementia Research Group’s (10/66 DRG) popu-
lation-based studies of ageing and dementia in LMICs
comprised baseline surveys of all older people aged 65
years and over living in geographically-defined catch-
ment areas in seven countries, with a follow-up 3–5
years later. For the current analyses, this comprises
urban and rural sites in China, Mexico and Peru, and
urban sites in Cuba, Dominican Republic, Venezuela
and India. Baseline population-based surveys were carried
out between 2003 and 2007, and incidence wave follow-up
assessments between 2008 and 2010. For India, the
follow-up comprised a mortality sweep only. The de-
sign of the baseline and follow-up phases of the 10/66
DRG research program have been described in detail
elsewhere [19]. Here, we will describe aspects directly
relevant to the analyses presented in this paper.Ethical issues
Participants were recruited following informed signed
consent. Persons with dementia who lacked capacity for
consent were recruited on the basis of a relative’s signed
agreement. Illiterate persons were read the information
sheet and consent form, and invited to express their con-
sent verbally, which was witnessed. Studies were approved
by local ethical committees as well as by the ethical com-
mittee of the Institute of Psychiatry, King’s College London.Exposures – Frailty
Frailty indicators
We assessed seven indicators of frailty, namely exhaustion,
weight loss, slow walking speed, low energy expenditure
(physical inactivity), undernutrition, and cognitive and sen-
sory impairment. These were operationalized as follows:
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from the Geriatric Mental Status examination.
Participants who reported feeling worn out or
exhausted were considered to have this frailty [20].
2. Weight loss: Self-reported weight loss was assessed
using a single item from the Geriatric Mental State
(Q53.1) “Have you lost any weight in the last three
months?” Those reporting weight loss of 10 lbs (4.5 kg)
or more in last three months were considered to have
this frailty [20].
3. Slow walking speed: assessed using a standard timed
walking test in which the participant was asked to
walk 5 metres at usual speed, turn, and return to the
starting point. Those taking 16 seconds or longer to
complete the task were considered to have a slow
walking speed.
4. Low energy expenditure: in response to the question
“Taking into account both work and leisure, would
you say that you are: very, fairly, not very or not at
all physically active?” Those that rated themselves
not at all physical active were considered physically
inactive.
5. Undernutrition: assessed through the measurement
of mid-upper arm circumference, those with a circum-
ference of <22 cm were considered to be frail. This
cut-point is used in the Mini Nutritional Assessment®
to identify the most severe level of undernutrition
according to this index [21].
6. Cognitive impairment: cognitive function was assessed
using the Community Screening Instrument for
Dementia COGSCORE, which tests multiple domains
of cognitive function, and has been found to have
robust cross-cultural measurement properties in the
10/66 study sites [22]. Frailty was defined according to
the higher of two possible cut-points (29.5, for ‘possible
dementia’) in order to identify cognitive impairment
beyond dementia.
7. Sensory impairment: assessed according to self-report
(from two separate items) of having ‘eyesight problems’
or ‘hearing problems or deafness’, which interfered with
activities to at least some extent.Frailty phenotypes
Physical frailty model
Fried et al.’s physical frailty model [23] proposes five specific
and measurable indicators to identify frailty (exhaustion,
weight loss, weak grip strength, slow walking speed, and
low energy expenditure). Individuals are identified as frail if
they meet three or more of the five criteria, as intermediate
if they meet one or two, and as non-frail if they meet none
of the five criteria [4]. We applied our exhaustion, weight
loss, slow walking speed, and low energy expenditure
indicators. Since handgrip strength was not measuredwe considered participants as frail if they fulfilled two
or more of the four frailty indicators.
Multidimensional frailty
The approach developed in the Alameda County study
comprised 16 self-reported items grouped into four do-
mains of functioning (physical, nutrition, cognitive, and
sensory) [16]. The physical functioning domain included
dizziness, loss of balance, weakness in the arms, and
weakness in the legs. The nutritive functioning domain
included loss of appetite and unexplained weight loss.
The cognitive functioning domain included memory and
attention difficulties. The sensory functioning domain in-
cluded vision and hearing difficulties in different situations.
Participants were classified as frail if they had difficulties in
two or more domains. We applied our slow walking speed,
undernutrition, cognitive impairment, and sensory impair-
ment indicators.
Covariates – measures of socio-demographic circum-
stances, morbidity, and disability
Age, sex, and educational level were important determi-
nants of mortality [24] and dependence in our LMIC sites
[25]. Participants’ ages were established during the baseline
interview, from stated age, official documentation, inform-
ant report, and, in the case of discrepancy, age according to
an event calendar. We also recorded the participant’s
gender and educational level (none; some but did not
complete primary; completed primary; completed sec-
ondary; tertiary).
We summarised the impact of physical, mental and
cognitive health through measurement and control for
stroke, physical impairments, dementia and depression –
conditions previously shown to make a substantial con-
tribution to disability and dependence [25, 26]. These
were assessed as follows:
1. Dementia diagnosed according to the cross-culturally
developed, calibrated and validated 10/66 dementia
diagnosis algorithm, on the basis of cognitive testing,
clinical mental state interview and informant
interview [22].
2. Self-reported stroke, confirmed by the interviewer as
having characteristic symptoms lasting for more
than 24 hours [27].
3. Number of self-reported limiting physical impairments
from a list of nine (arthritis or rheumatism; persistent
cough; breathlessness, difficulty breathing or asthma;
high blood pressure; heart trouble or angina; stomach
or intestine problems; faints or blackouts; paralysis,
weakness or loss of one leg or arm; skin disorders such
as pressure sores, leg ulcers or severe burns).
4. International Classification of Diseases-10 depressive
episode (mild, moderate or severe), derived using a
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interview, the Geriatric Mental State [26].
Disability was assessed as activity limitation and par-
ticipation restriction measured by the World Health
Organization Disability Assessment Scale 2.0, developed
as a culture-fair assessment tool for use in cross-cultural
comparative epidemiological and health services research
[28]. We had previously demonstrated measurement in-
variance across the sites included in our survey.
Outcomes
In the incidence wave we sought to trace and re-interview
all baseline survey participants. We first called on their
residence at baseline, revisiting on up to four occasions.
Where the participant was no longer resident we sought
information regarding their vital status (if known) and/or
current residence, assisted by having recorded, at baseline,
the names and addresses of three non-coresident friends
or family members. Where participants had moved away,
we sought to re-interview them, even if they had moved
out of the original catchment area, by telephone if neces-
sary. Where a participant had died, we recorded date of
death, and completed a verbal autopsy interview with a
suitable key informant.
Dependence (need for care) was identified through a
series of open-ended questions to a key informant: Who
shares the home? What kind of help does the participant
need inside and outside of the home? Who, in the family,
is available to care? What help do you provide? Do you
help to organise care? Is there anyone else in the family
who is more involved in helping? What do they do? What
about friends and neighbours, what do they do? The inter-
viewer then coded whether the participant required no
care, care some of the time, or care much of the time [29].
The same approach was used at baseline and follow-up
surveys. Those with no needs for care at baseline were
considered to be at risk for the incidence of dependence,
and those among them who were rated as needing care
some of the time or much of the time at follow-up were
considered to have incident dependence.
Analysis
All data was double entered into EPIDATA software and
data analysis was performed using STATA version 10.
We describe the principal characteristics of the mortality
cohort (the whole baseline survey sample, at risk for
mortality), and the dependence cohort (those with no
needs for care at baseline, hence at risk for the onset of
dependence). Person-years risk for the onset of depend-
ence was calculated as the interval between baseline and
follow-up assessment, or the mid-point of this interval
for those who developed dependence. We used Poisson
regression to estimate incidence rate ratios (IRR) forassociations with incident dependence. We used Cox’s
proportional hazards regression to estimate hazard ratios
for associations with mortality. Survival times were cen-
sored on the date of death, or the date of follow-up for
those who were re-interviewed, or the median date of
follow-up interview in that site for those refusing interview.
We first assessed the associations of the dichotomized
frailty syndromes (defined according to physical and multi-
dimensional frailty criteria) with both outcomes, controlling
incrementally for age, sex and education (model 1), these
factors plus health conditions (dementia, depression, num-
ber of physical impairments and stroke – model 2), and all
of these factors plus disability (model 3). We ran the
models in each site, and then used a fixed or random effects
meta-analysis to combine them. Higgins I2 was computed,
estimating the proportion of between-site variability in the
estimates accounted for by heterogeneity, as opposed to
sampling error; up to 40 % heterogeneity is conventionally
considered negligible, while up to 60 % may reflect moder-
ate heterogeneity [30]. For model 2 (controlling for age,
sex, education and health conditions, but not disability) we
used the STATA aflogit command to calculate PAF % with
95 % confidence intervals (CIs) for the contribution of
frailty syndromes to the incidence of dependence and
mortality, comparing the dichotomised frailty syndrome
with two alternative approaches; either using the number
of indicators (0 to 4) as an ordinal scale, or the aggregate
effect of the four individual indicators. We also estimated
the aggregate effect of all seven frailty indicators entered
simultaneously. The STATA aflogit command estimates
the individual and combined attributable fractions ro-
bustly from within the Poisson regression framework.
PAFs represent the proportion of the incidence of the
outcome that could theoretically be avoided if the exposure
could be removed from the population, assuming causal
relationships estimated free of confounding. Finally, we
estimated and compared the effects of each of the seven
individual frailty indicators for associations with incident
dependence (pooled meta-analysed IRR) and mortality
(pooled meta-analysed HR) controlling as per model 2
above for demographic variables and health conditions.
Results
The mortality cohort comprised 13,924 individuals at base-
line. Vital status was ascertained at follow-up in 88.9 %
(n = 12,373) ranging from 74.4 % to 100 % by site. Median
years of follow-up ranged from 2.8 to 5.0 years, because of
the variation among sites in the period in which the base-
line surveys were conducted; overall, 47,439 person-years
of mortality follow-up were accumulated. Mortality rates
ranged from 27.3/1000 person-years (urban Peru) to 70.0/
1000 person-years in urban India. The dependence cohort
comprised 11,251 individuals, with no needs for care at
baseline; 7,910 (70.3 %) were successfully reinterviewed
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724 (6.4 %) refused, and 1,116 (9.9 %) could not be con-
tacted. The incidence of dependence ranged from 22.3/
1000 (rural China) to 50.0/1000 person-years (urban
China). In the full baseline sample (mortality cohort) the
prevalence of frailty was 17.5 % according to the physical
frailty and 29.1 % according to multidimensional frailty
criteria. There was considerable variation among sites,
with the highest prevalence observed in the Dominican
Republic (34.6 % physical and 47.8 % multidimensional
frailty) and the lowest in urban China (7.8 % physical and
11.3 % multidimensional frailty). Prevalence of frailty ac-
cording to multidimensional criteria was generally higher
than that for physical frailty. Among those without needs
for care at baseline (the dependence cohort), the preva-
lence of frailty was somewhat lower, 13.5 % according to
physical frailty criteria, and 22.5 % according to multidi-
mensional criteria (Table 1).
The meta-analysed effects of frailty on the incidence of
dependence and mortality are presented in Table 2. Both
the physical and the multidimensional dichotomous
frailty definitions independently predicted the onset of
dependence and mortality. Effect sizes were progres-
sively attenuated after controlling sequentially for demo-
graphic factors, chronic health conditions and disability,
but remained statistically significant. The heterogeneity
among sites in the estimates of association is minimal to
moderate throughout, and only those for the association
between frailty according to the multidimensional criteria
and mortality are statistically significant.
Next, we compared the physical and multidimensional
frailty phenotypes as dichotomised syndromes, ordinal
scales, and as the aggregate of their individual indicators,
with respect to the PAFs for their independent contribu-
tion to the onset of dependence (Table 3) and mortality
(Table 4). For both outcomes, the contributions of the
ordinal scale and of the aggregate of the individual indi-
cators of frailty consistently exceeded those for the di-
chotomous definition, and the aggregate contribution of
the individual indicators generally exceeded that of the
ordinal scale. For the physical frailty models, the PAFs
for dependence for the dichotomous definition range
from 3.1 % to 26.7 % (weighted mean 9.5 %), for the ordinal
scale from 3.3 % to 43.4 % (weighted mean 18.6 %), and for
the individual indicators from 3.6 % to 62.1 % (weighted
mean 23.2 %). For the multidimensional frailty model, the
PAFs for dependence for the dichotomous definition range
from 7.0 % to 31.0 % (weighted mean 18.0 %), for the or-
dinal scale from 5.5 % to 47.7 % (weighted mean 31.3 %),
and for the individual indicators from 15.2 % to 58.3 %
(weighted mean 36.9 %). The PAFs for mortality for the di-
chotomous definition of the Fried frailty model range from
0.8 % to 18.9 % (weighted mean 10.5 %), for the ordinal
scale from 0.6 % to 40.3 % (weighted mean 20.9 %), and forthe individual indicators from 8.9 % to 46.5 % (weighted
mean 25.1 %). For the multidimensional frailty model, the
PAF for dependence for the dichotomous definition range
from 5.3 % to 42.2 % (weighted mean 19.6 %), for the or-
dinal scale from 4.3 % to 49.8 % (weighted mean 28.3 %),
and for the individual indicators from 7.7 % to 56.2 %
(weighted mean 33.4 %). In general, the aggregate effect
of all seven indicators exceeded that for any of the uni-
dimensional or multidimensional operationalisations with a
weighted mean PAF of 41.8 % for dependence and 38.3 %
for mortality.
In Table 5, the independent associations between indi-
vidual frailty indicators (from both frailty paradigms) and
incident dependence and mortality are presented. Data
from all sites were combined together and meta-analysed
to estimate pooled effect sizes. After controlling for demo-
graphic factors and chronic health conditions, weight loss,
underactivity, slow walking speed, and cognitive impair-
ment were associated with both outcomes. Undernutrition
(arm circumference) was particularly strongly associated
with mortality, but was not associated with incident de-
pendence. Conversely, sensory impairment was weakly
associated with onset of dependence, and was not associ-
ated with mortality. Exhaustion was not associated with
either outcome. Heterogeneity in the effect sizes among
sites was negligible to moderate, and only statistically sig-
nificant for the associations between slow walking speed
and cognitive impairment with incident dependence, and
for the association of weight loss with mortality.
Discussion
We have found, in a large population-based cohort study
in LMICs, that both the physical and multidimensional
frailty phenotypes predict the onset of dependence and
mortality, even after adjusting for chronic diseases and
baseline disability scores (Table 2). However, analysis of
PAFs suggests that treating the number of underlying frailty
indicators as ordinal scales, and, to an even greater extent,
considering the aggregate effect of individual frailty in-
dicators, provides a better overall prediction of risk of
experiencing these adverse outcomes. Combining the seven
indicators underlying both phenotypes provided the best
overall prediction. While some of these seven indicators
(weight loss, under activity, slow walking speed, and
cognitive impairment) predicted both dependence and
mortality, undernutrition predicted mortality only, and sen-
sory impairment predicted dependence only; self-reported
exhaustion predicted neither outcome.
The analyses were conducted on large population-based
samples in Latin America, India, and China, hence allowing
us to assess the consistency or cultural specificity of the ob-
served associations. The study design was prospective, lim-
iting information bias, with modest attrition. Measurement
error will have occurred, but, if random, the effect will have
Table 1 Cohort characteristics
Cuba Dominican
Republic











Baseline sample (alive at
baseline)
2813 2011 1381 552 1997 1003 1000 1160 1002 1005 13924
Vital status determined
(% of baseline sample)
2637 (93.7 %) 1706 (84.8 %) 1245 (90.2 %) 507 (91.8 %) 1697 (84.5 %) 909 (90.6 %) 933 (93.3 %) 989 (85.2 %) 1002 (100.0 %) 748 (74.4 %) 12373 (88.9 %)
Deaths (% of those with vital
status determined)
609 (23.1 %) 467 (27.4 %) 98 (7.9 %) 54 (10.6 %) 200 (11.8 %) 99 (10.9 %) 110 (11.8 %) 224 (22.6 %) 291 (29.0 %) 154 (20.6 %) 2306 (18.6 %)
Person years of follow-up 10852.5 7448.6 3592.7 1764.1 7031.1 2667.1 2689.3 4630.6 4563.3 2198.7 47437.9
Mortality rate (per 1000
person-years)












63.8 (56.8–71.4) 70.0 (59.6–
81.8)
56.1 (51.8–60.7)
Median years of follow-up
(25th and 75th centile)
4.2 (3.5–5.0) 5.0 (3.6–5.1) 2.8 (2.4–3.4) 3.7 (3.6–3.8) 4.2 (4.0–4.8) 3.0 (2.9–3.2) 3.0 (2.9–3.1) 4.9 (4.6–5.3) 4.9 (4.4–5.2) 2.9 (2.5–3.6) 3.9 (3.0–4.9)
Mean age at baseline (SD) 75.2 (7.1) 75.4 (7.6) 75.0 (7.4) 74.1 (7.3) 72.3 (6.8) 74.4 (6.6) 74.1 (6.6) 74.1 (6.3) 72.4 (6.0) 71.4 (6.1) 74.1 (7.0)
Female sex (%) 1714 (65.0 %) 1130 (66.3 %) 805 (64.7 %) 270 (53.2 %) 1072 (63.2 %) 605 (66.5 %) 569 (60.9 %) 560 (56.6 %) 556 (55.5 %) 422 (57.2 %) 7703 (62.3 %)
Did not complete primary
education (%)
661 (25.1 %) 1211 (71.7 %) 114 (9.2 %) 206 (41.3 %) 499 (30.0 %) 530 (58.4 %) 787 (84.2 %) 346 (35.0 %) 693 (69.2 %) 492 (66.0 %) 5539 (45.1 %)
Fried frailty model 554 (21.0 %) 591 (34.6 %) 323 (25.9 %) 87 (17.2 %) 187 (11.0 %) 92 (10.1 %) 79 (8.5 %) 77 (7.8 %) 87 (8.7 %) 85 (11.4 %) 2162 (17.5 %)
Multidimensional frailty
model
889 (33.7 %) 816 (47.8 %) 351 (28.2 %) 130 (25.6 %) 340 (20.0 %) 208 (22.9 %) 338 (36.2 %) 112 (11.3 %) 225 (22.5 %) 195 (26.1 %) 3604 (29.1 %)
DEPENDENCE COHORT
Baseline sample (no needs
for care at baseline)
2225 1770 1246 524 1754 889 918 977 948 11251
Re-interviewed (% of baseline
sample)
1662 (74.7 %) 1144 (64.6 %) 830 (66.6 %) 399 (76.1 %) 1154 (65.8 %) 688 (77.4 %) 664 (72.3 %) 671 (68.7 %) 698 (73.6 %) – 7910 (70.3 %)
Incident dependence (% of
those re-interviewed)
233 (14.0 %) 242 (21.2 %) 95 (11.4 %) 38 (9.5 %) 181 (15.7 %) 90 (13.1 %) 90 (13.6 %) 151 (22.5 %) 74 (10.6 %) – 1194 (15.1 %)
Person years of follow-up 7031.6 5002.0 2317.1 1414.5 4702.4 1979.3 1900.4 3020.7 3320.7 – 30688.8
Incidence rate (per 1000
person-years)












22.3 (17.6–27.8) – 38.9 (36.7–41.2)
Median years of follow-up
(25th and 75th centile)
4.3 (3.6–5.1) 5.0 (4.8–5.2) 2.8 (2.4–3.2) 3.7 (3.6–3.7) 4.2 (4.0–4.7) 3.0 (2.9–3.2) 3.0 (2.9–3.1) 4.9 (4.4–5.3) 4.9 (4.7–5.3) – 4.0 (3.0–4.9)
Mean age at baseline (SD) 73.5 (6.2) 73.6 (6.6) 74.1 (6.8) 73.2 (6.7) 71.1 (5.8) 73.4 (6.0) 73.5 (6.3) 72.4 (5.3) 71.0 (5.1) – 72.9 (6.2)













Table 1 Cohort characteristics (Continued)
Did not complete primary
education (%)
356 (21.4 %) 797 (69.9 %) 69 (8.4 %) 153 (38.9 %) 302 (26.3 %) 379 (55.3 %) 549 (82.6 %) 226 (33.7 %) 467 (66.9 %) – 3298 (41.8 %)
Fried frailty model 258 (15.5 %) 347 (30.3 %) 185 (22.3 %) 58 (14.5 %) 89 (7.7 %) 57 (8.3 %) 37 (5.6 %) 5 (0.7 %) 33 (4.7 %) – 1069 (13.5 %)
Multidimensional frailty
model













Table 2 Meta-analysed effects of dichotomous frailty indicators (physical and multidimensional frailty models) on the incidence of
dependence and mortality, controlling sequentially for health conditions and disability
Model 1 (age, sex and education) Model 2 (model 1 + health conditions)a Model 3 (model 2 + disability)b
Physical frailty phenotype
Dependence (IRR)c Fd = 1.77 (1.53–2.04) F = 1.43 (1.24–1.64) F = 1.28 (1.10–1.48)
Heterogeneity Cochrane’s Q 14.1, 8 df, P = 0.08 Cochrane’s Q 13.9, 8 df, P = 0.09 Cochrane’s Q 10.0, 8 df, P = 0.27
Higgins I2 = 43 (0–74) Higgins I2 = 42 (0–73) Higgins I2 = 20 (0–61)
Mortality (HR)e F = 1.89 (1.72–2.08) F = 1.51 (1.36–1.68) F = 1.18 (1.06–1.33)
Rf = 1.97 (1.68–2.31)
Heterogeneity Cochrane’s Q 20.1, 9 df, P = 0.02 Cochrane’s Q 15.0, 9 df, P = 0.09 Cochrane’s Q 10.8, 9 df, P = 0.29
Higgins I2 = 55 (9–78) Higgins I2 = 40 (0–71) Higgins I2 = 16 (0–58)
Multidimensional phenotype
Dependence (IRR) F = 2.15 (1.88–2.46) F = 1.46 (1.27–1.68) F = 1.36 (1.18–1.57)
Heterogeneity Cochrane’s Q 2.9, 8 df, P = 0.95 Cochrane’s Q 6.1, 8 df, P = 0.64 Cochrane’s Q 3.5, 8 df, P = 0.90
Higgins I2 = 0 (0–65) Higgins I2 = 0 (0–65) Higgins I2 = 0 (0–65)
Mortality (HR) F = 1.96 (1.78–2.15) F = 1.54 (1.39–1.71) F = 1.38 (1.24–1.54)
R = 1.94 (1.66–2.28) R = 1.53 (1.29–1.81) R = 1.36 (1.14–1.62)
Heterogeneity Cochrane’s Q 21.1, 9 df, P = 0.01 Cochrane’s Q 19.7, 9 df, P = 0.02 Cochrane’s Q 19.8, 9 df, P = 0.02
Higgins I2 = 57 (14–79) Higgins I2 = 54 (7–78) Higgins I2 = 55 (8–78)
a10/66 or DSM-IV dementia diagnosis, ICD-10 depression, number of physical impairments and stroke; bWHO Disability Assessment Scale 2.0; cIRR, Incidence rate
ratio; dF, Pooled fixed effect; eHR, Hazard ratio; fR, Pooled random effect (estimated only in the presence of statistically significant heterogeneity)
AT et al. BMC Medicine  (2015) 13:138 Page 8 of 12been systematically to underestimate the effect of frailty
exposures on mortality and dependence. We studied a
wide range of frailty indicators comprising most of those in-
cluded in the most widely used frailty phenotypes. Walking
speed, undernutrition and cognitive impairment were mea-
sured objectively, an advantage over some other studies that
relied entirely on self-report [16]. Visual and auditory im-
pairment probably would also have been more accurately
and appropriately assessed by objective testing. We were
able to control fairly comprehensively for physical, mental,Table 3 Population attributable fractions (PAF % with 95 % confiden
incidence of dependence, when operationalised as dichotomous ca
Physical frailty criteria
Dichotomous Ordinal scale Individual
indicators
Cuba 10.3 (2.9–17.2) 27.0 (15.2–37.2) 28.0 (16.4–38.1)
Dominican
Republic
3.1 (0.0–8.6) 3.3 (0.0–15.3) 3.6 (0.0–8.3)
Peru (urban) 9.4 (0.0–20.1) 11.1 (0.0–29.2) 17.8 (0.0–39.4)
Peru (rural) 26.7 (2.3–45.2) 43.4 (0.0–68.8) 62.1 (0.0–86.7)
Venezuela 15.5 (3.9–25.7) 30.8 (12.7–45.1) 30.4 (10.1–46.1)
Mexico (urban) 5.9 (0.0–18.5) 16.2 (0.0–40.0) 24.8 (0.0–49.9)
Mexico (rural) 11.1 (0.0–23.3) 13.0 (0.0–32.7) 27.0 (0.0–47.0)






Weighted mean 9.5 18.6 23.2and cognitive disorders that are the major predictors
of mortality and dependence, and for disability, hence
precisely estimating the independent contribution of frailty
to those outcomes. Handgrip strength was not measured in
our surveys; thus, our physical frailty construct is only an
approximation to the original Fried definition. The impact
of this omission is difficult to assess. A recent meta-analysis
indicates that handgrip strength is a consistent predictor of
mortality, although effect sizes vary markedly among
studies [31]. While, in this meta-analysis, the effect sizesce intervals) for the independent contribution of frailty to the
tegories, ordinal scales or individual indicators




Dichotomous Ordinal scale Individual
indicators
23.5 (10.7–34.5) 40.9 (26.7–52.3) 43.5 (30.7–54.0) 44.5 (31.8-54.9)
7.6 (0.0–18.4) 18.5 (0.0–34.9) 22.1 (1.7–38.2) 24.4 (4.1-40.4)
31.0 (4.2–50.3) 46.6 (15.6–66.3) 58.3 (37.6–72.1) 60.7 (43.2-72.8)
22.9 (0.0–48.5) 47.7 (0.0–73.7) 49.9 (1.4–74.5) 72.5 (1.5-92.3)
21.5 (6.1–34.4) 47.6 (30.5–60.5) 49.0 (30.8–62.4) 54.6 (35.7-68.0)
17.0 (0.0–35.2) 31.6 (1.2–52.6) 42.0 (9.0–63.1) 42.8 (7.8-64.5)
7.0 (0.0–25.0) 5.5 (0.0–36.0) 15.2 (0.0–35.5) 25.6 (0.0-46.7)
14.4 (0.0–34.9) 24.0 (0.0–46.4) 28.0 (2.7–46.6) 38.5 (11.4-57.3)
13.0 (0.0–37.6) 5.7 (0.0–43.3) 16.6 (0.0–38.3) 20.4 (0.0-58.7)
18.0 31.3 36.9 41.8
Table 4 Population attributable fractions (PAF % with 95 % confidence intervals) for the independent contribution of frailty to the
incidence of mortality, when operationalised as dichotomous categories, ordinal scales or individual indicators




Dichotomous Ordinal scale Individual indicators Dichotomous Ordinal scale Individual indicators
Cuba 8.8 (6.5–11.0) 16.5 (12.0–20.8) 13.6 (8.1–18.7) 20.1 (15.5–24.4) 30.2 (24.3–35.6) 30.4 (24.0–36.2) 29.8 (22.8–36.1)
Dominican Republic 5.4 (2.3–7.7) 17.8 (12.4–22.8) 20.5 (14.9–25.7) 13.1 (8.6–17.5) 21.8 (14.4–28.6) 30.0 (23.4–36.0) 33.5 (27.2–39.3)
Peru (urban) 13.6 (4.9–21.6) 26.0 (11.9–37.9) 40.0 (22.2–53.8) 42.2 (22.5–56.9) 49.8 (28.7–64.6) 56.2 (38.9–68.6) 56.7 (39.5–69.0)
Peru (rural) 0.8 (0.0–10.1) 0.6 (0.0–19.7) 13.6 (0.0–30.1) 27.5 (5.5–44.4) 29.2 (0.0–52.7) 34.5 (7.1–53.9) 34.9 (3.8–55.9)
Venezuela 17.5 (11.2–23.4) 32.5 (23.0–40.8) 38.1 (24.5–49.3) 21.9 (12.4–30.4) 41.8 (29.3–52.1) 51.6 (37.8–62.3) 55.0 (41.3–65.6)
Mexico (urban) 12.8 (2.9–21.7) 20.3 (0.0–36.8) 8.9 (0.2–16.8) 15.7 (0.7–28.4) 29.2 (4.1–47.7) 22.3 (0.0–44.9) 24.1 (1.8–41.4)
Mexico (rural) 18.9 (9.4–27.4) 40.3 (25.8–52.0) 46.5 (32.3–57.8) 10.9 (0.0–23.6) 16.4 (0.0–33.9) 36.3 (17.3–50.9) 49.0 (35.1–59.9)
China (urban) 14.5 (10.4–18.4) 30.7 (24.6–36.2) 31.7 (25.1–37.8) 5.3 (0.0–12.2) 17.1 (6.8–26.2) 26.4 (16.3–35.3) 36.1 (26.1–44.8)
China (rural) 3.4 (1.7–5.1) 5.9 (0.5–11.0) 25.7 (14.5–35.3) No association 4.3 (0.0–10.5) 7.7 (1.4–13.6) 33.8 (18.9–46.0)
India (urban) 5.4 (0.1–10.4) 6.6 (0.0–17.1) 13.8 (4.9–21.9) 19.7 (11.7–27.0) 30.0 (18.0–40.3) 25.1 (9.6–37.9) 25.3 (10.4–37.7)
Weighted mean 10.5 20.9 25.1 19.6 28.3 33.4 38.3
AT et al. BMC Medicine  (2015) 13:138 Page 9 of 12for walking speed were larger, the authors cautioned
against inferring too much from this finding, pointing
out the few studies of walking speed, the correlation
among frailty indicators, and the few studies that had
estimated their independent effects. In two longitudinalTable 5 Meta-analysed pooled effect sizes for the independent asso
dependence and mortality
Associations with incident dependence
Frailty indicator Mutually adjusteda pooled
effect size (IRR) b
Test for h
Exhaustion Fd = 1.03 (0.90–1.17) Cochrane
P = 0.37
Higgins I
Weight loss F = 1.31 (1.06–1.61) Cochrane
P = 0.21
Higgins I
Underactivity F = 1.35 (1.10–1.67) Cochrane
P = 0.16
Higgins I
Slow walking speed F = 1.28 (1.12–1.47) Cochrane
P = 0.03
R = 1.30 (1.05–1.61) Higgins I
Sensory impairment F = 1.14 (1.01–1.29) Cochrane
P = 0.52
Higgins I
Cognitive impairment F = 1.53 (1.30–1.79) Cochrane
P = 0.03
R = 1.48 (1.16–1.90) Higgins I
Undernutrition (arm
circumference <22 cm)
F = 1.11 (0.89–1.38) Cochrane
P = 0.11
Higgins I
aThe effect of each frailty indicator is adjusted for all of the others, in models also c
or DSM-IV dementia diagnosis, ICD-10 depression, number of physical impairments
eR, Pooled random effect (estimated only in the presence of statistically significantstudies that did seek to do this, the effect of handgrip
strength on incident disability [2, 32] and mortality [32]
were attenuated and no longer significant when adjusted
for other frailty indicators and potential confounders [2,
32]. We also acknowledge that the only definition of self-ciations between individual frailty indicators and incident
Associations with mortality
eterogeneity Mutually adjusteda pooled
effect size (HR)c
Test for heterogeneity
’s Q 8.6, 8 df, F = 1.00 (0.90–1.12) Cochrane’s Q 10.4, 9 df,
P = 0.32
2 = 7 (0–67) Higgins I2 13 (0–55)
’s Q 8.4, 6 df, F = 1.40 (1.19–1.64) Cochrane’s Q 17.7, 9 df,
P = 0.04
2 = 28 (0–69) R5 = 1.45 (1.13–1.87) Higgins I2 49 (0–75)
’s Q 11.8, 8 df, F = 1.53 (1.32–1.88) Cochrane’s Q 12.8, 9 df,
P = 0.17
2 = 32 (0–69) Higgins I2 30 (0–66)
’s Q 17.0, 8 df, F = 1.36 (1.21–1.51) Cochrane’s Q 14.7, 9 df,
P = 0.10
2 = 53 (0–78) Higgins I2 39 (0–71)
’s Q 7.2, 8 df, F = 1.03 (0.93–1.14) Cochrane’s Q 6.9, 9 df,
P = 0.65
2 = 0 (0–65) Higgins I2 0 (0–62)
’s Q 16.9, 8 df, F = 1.38 (1.23–1.54) Cochrane’s Q 15.1, 9 df,
P = 0.09
2 = 53 (0–78) Higgins I2 40 (0–71)
’s Q 10.4, 6 df, F = 1.72 (1.47–2.01) Cochrane’s Q 9.2, 9 df,
P = 0.41
2 = 42 (0–76) 3 (0–63)
ontrolling for age group, sex, level of education, and health conditions (10/66
and stroke); bIRR, Incidence rate ratio; cHR, Hazard ratio; dF, Pooled fixed effect;
heterogeneity)
AT et al. BMC Medicine  (2015) 13:138 Page 10 of 12reported weight loss available in our study (>4.5 kg in the
last three months) is more precipitate than that used in
the Fried criteria (>4.5 kg in the past year), and may inflate
the association between that criterion and mortality
due to the marked weight loss associated with terminal
conditions.
Our findings regarding the predictive validity of the
two frailty models are partly consistent with other stud-
ies. In a 4-year prospective community-based cohort
study in three French cities, the Fried frailty phenotype
was associated with in increased incidence of disability,
independent of cognitive impairment [15, 33]. In the
12-country Survey of Health and Retirement in Europe,
those meeting Fried frailty criteria had nearly a five times
higher odds of death compared to non-frail individuals
[34]. Most frailty studies have been conducted in developed
countries. Two prospective studies from China and one
from Mexico have demonstrated prospective associations
between frailty indices (a composite of indicators of phys-
ical impairment, chronic disease diagnoses, activity limita-
tion and disability) and mortality [35–37]. The justification
for considering frailty as a unitary construct (‘frailty’ rather
than ‘frailties’) seems not previously to have been subjected
to critical empirical examination. Our finding that slow gait
speed, low physical inactivity, weight loss, and cognitive
impairment were associated both with mortality and de-
pendence, but that self-reported exhaustion was associated
with neither outcome, replicates precisely a finding from an
earlier North American cohort study [32]. Variable predict-
ive associations among frailty indicators explain our finding
that the overall prediction of mortality and dependence is
significantly reduced when the information from the vari-
ous indicators is summarised as a dichotomous syndrome.
The implicit assumption, that these are all indicators of a
unidimensional latent trait, is challenged by our finding
that the prediction provided by the aggregate of individual
indicators exceeds that when the indicators are summed
to form an ordinal scale.
Conclusions
The results of our study support an emerging consensus
that further empirical work on the scope and dimensional-
ity of frailty, and the construct validity of its assessments
should be a priority for future research [38]. However,
even at this early stage in the detailed conceptualisation
and measurement of frailty, it seems clear that information
regarding variation in patterns of age-related change in
physiologic and organ/system function can help to stratify
risk for dependence and death, over and above any pre-
diction provided by clinical diagnoses and disability. This
principle extends to LMIC settings, according to the find-
ings reported in this paper. Frailty is a key outcome in
monitoring the public health response to the challenges
of global population ageing, in particular the holy grailof compression of morbidity. Frailty indicators may as-
sist in developing and targeting effective primary and
secondary prevention strategies to delay or prevent the
onset of dependence, and in providing holistic, coordinated
care for older people with complex multimorbidities,
particularly at the primary care level [39]. Evidence pre-
sented here supports the view that frailty is likely to be a
multidimensional construct [38], and that we need there-
fore to consider ‘frailties’ in different organ-based and
physiological systems, and their individual and joint
impacts on functional decline, loss of independence and
survival. There are likely to be benefits in moving beyond
the physical frailty phenotype to consider at least the ef-
fects of chronic undernutrition and sensory and cognitive
impairment [38]. A broader range of frailty indicators may
cluster into meaningful sub-domains of frailty with com-
mon underlying pathophysiological mechanisms [40]. It is
likely that more objective measurement of frailty indi-
cators (including underlying physiological biomarkers)
may provide better risk stratification. A better understand-
ing of the frailty phenotypes and the pathways to adverse
outcomes could inform simple multi-dimensional assess-
ment and multi-component intervention strategies with
considerable potential to add life to years as well as years
to life [41]. Such approaches may have particular value
in resource-poor LMIC settings, where population age-
ing is proceeding most rapidly, dependence is already
highly prevalent [25], and where numbers of dependent
older people are forecast to quadruple between 2000 and
2050 [41].
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